Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gene therapy refers to the introduction of exogenous normal genes into target cells to correct or compensate for diseases caused by defective and abnormal genes in order to achieve therapeutic goals.
In recent years, gene therapy has been used with increased frequency to treat a variety of rare and incurable diseases, such as cancer and genetic disorders. Increased funding for cellular gene therapy companies in European countries such as the UK is expected to drive the European market at a considerable growth rate. Moreover, European companies are committed to expand product distribution globally by obtaining approvals from several regulatory bodies. China is recognized as a global focus for the development of new therapies. In the current scenario, the number of ongoing clinical trials for gene therapies in China has surpassed the number of trials in the US. The Asia-Pacific gene therapy market is also expected to grow.
Gene therapy can provide a fundamental solution to many difficult conditions such as cancer, and with the increasing research in biotechnology, more gene therapies will be found, which is expected to drive the gene therapy market.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Gene Therapy market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Gene Therapy market. Detailed analysis of key players, along with key growth strategies adopted by Gene Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Celladon
Advantagene
Sangamo
Dimension Therapeutics
Vical
Avalanche Bio
Spark Therapeutics
By Type:
Lentivirus
AAV
Retrovirus & Gammaretrovirus
Modified Herpes Simplex Virus
Adenovirus
Non-viral Plasmid Vector
By End-User:
Acute Lymphoblastic Leukemia (ALL)
Inherited Retinal Disease
Large B-cell Lymphoma
ADA-SCID
Melanoma (Lesions)
Beta-Thalassemia Major/SCD
Head & Neck Squamous Cell Carcinoma
Peripheral Arterial Disease
Spinal Muscular Atrophy (SMA)
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Gene Therapy Market
-
1.3 Market Segment by Type
-
1.3.1 China Gene Therapy Market Size and Growth Rate of Lentivirus from 2016 to 2027
-
1.3.2 China Gene Therapy Market Size and Growth Rate of AAV from 2016 to 2027
-
1.3.3 China Gene Therapy Market Size and Growth Rate of Retrovirus & Gammaretrovirus from 2016 to 2027
-
1.3.4 China Gene Therapy Market Size and Growth Rate of Modified Herpes Simplex Virus from 2016 to 2027
-
1.3.5 China Gene Therapy Market Size and Growth Rate of Adenovirus from 2016 to 2027
-
1.3.6 China Gene Therapy Market Size and Growth Rate of Non-viral Plasmid Vector from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Gene Therapy Market Size and Growth Rate of Acute Lymphoblastic Leukemia (ALL) from 2016 to 2027
-
1.4.2 China Gene Therapy Market Size and Growth Rate of Inherited Retinal Disease from 2016 to 2027
-
1.4.3 China Gene Therapy Market Size and Growth Rate of Large B-cell Lymphoma from 2016 to 2027
-
1.4.4 China Gene Therapy Market Size and Growth Rate of ADA-SCID from 2016 to 2027
-
1.4.5 China Gene Therapy Market Size and Growth Rate of Melanoma (Lesions) from 2016 to 2027
-
1.4.6 China Gene Therapy Market Size and Growth Rate of Beta-Thalassemia Major/SCD from 2016 to 2027
-
1.4.7 China Gene Therapy Market Size and Growth Rate of Head & Neck Squamous Cell Carcinoma from 2016 to 2027
-
1.4.8 China Gene Therapy Market Size and Growth Rate of Peripheral Arterial Disease from 2016 to 2027
-
1.4.9 China Gene Therapy Market Size and Growth Rate of Spinal Muscular Atrophy (SMA) from 2016 to 2027
-
1.4.10 China Gene Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Gene Therapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Gene Therapy by Major Types
-
3.4.1 Market Size and Growth Rate of Lentivirus
-
3.4.2 Market Size and Growth Rate of AAV
-
3.4.3 Market Size and Growth Rate of Retrovirus & Gammaretrovirus
-
3.4.4 Market Size and Growth Rate of Modified Herpes Simplex Virus
-
3.4.5 Market Size and Growth Rate of Adenovirus
-
3.4.6 Market Size and Growth Rate of Non-viral Plasmid Vector
4 Segmentation of Gene Therapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Gene Therapy by Major End-Users
-
4.4.1 Market Size and Growth Rate of Gene Therapy in Acute Lymphoblastic Leukemia (ALL)
-
4.4.2 Market Size and Growth Rate of Gene Therapy in Inherited Retinal Disease
-
4.4.3 Market Size and Growth Rate of Gene Therapy in Large B-cell Lymphoma
-
4.4.4 Market Size and Growth Rate of Gene Therapy in ADA-SCID
-
4.4.5 Market Size and Growth Rate of Gene Therapy in Melanoma (Lesions)
-
4.4.6 Market Size and Growth Rate of Gene Therapy in Beta-Thalassemia Major/SCD
-
4.4.7 Market Size and Growth Rate of Gene Therapy in Head & Neck Squamous Cell Carcinoma
-
4.4.8 Market Size and Growth Rate of Gene Therapy in Peripheral Arterial Disease
-
4.4.9 Market Size and Growth Rate of Gene Therapy in Spinal Muscular Atrophy (SMA)
-
4.4.10 Market Size and Growth Rate of Gene Therapy in Others
5 Market Analysis by Regions
-
5.1 China Gene Therapy Production Analysis by Regions
-
5.2 China Gene Therapy Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Gene Therapy Landscape Analysis
-
6.1 North China Gene Therapy Landscape Analysis by Major Types
-
6.2 North China Gene Therapy Landscape Analysis by Major End-Users
7 Central China Gene Therapy Landscape Analysis
-
7.1 Central China Gene Therapy Landscape Analysis by Major Types
-
7.2 Central China Gene Therapy Landscape Analysis by Major End-Users
8 South China Gene Therapy Landscape Analysis
-
8.1 South China Gene Therapy Landscape Analysis by Major Types
-
8.2 South China Gene Therapy Landscape Analysis by Major End-Users
9 East China Gene Therapy Landscape Analysis
-
9.1 East China Gene Therapy Landscape Analysis by Major Types
-
9.2 East China Gene Therapy Landscape Analysis by Major End-Users
10 Northeast China Gene Therapy Landscape Analysis
-
10.1 Northeast China Gene Therapy Landscape Analysis by Major Types
-
10.2 Northeast China Gene Therapy Landscape Analysis by Major End-Users
11 Southwest China Gene Therapy Landscape Analysis
-
11.1 Southwest China Gene Therapy Landscape Analysis by Major Types
-
11.2 Southwest China Gene Therapy Landscape Analysis by Major End-Users
12 Northwest China Gene Therapy Landscape Analysis
-
12.1 Northwest China Gene Therapy Landscape Analysis by Major Types
-
12.2 Northwest China Gene Therapy Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Celladon
-
13.1.1 Celladon Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Advantagene
-
13.2.1 Advantagene Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Sangamo
-
13.3.1 Sangamo Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Dimension Therapeutics
-
13.4.1 Dimension Therapeutics Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Vical
-
13.5.1 Vical Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Avalanche Bio
-
13.6.1 Avalanche Bio Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Spark Therapeutics
-
13.7.1 Spark Therapeutics Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Gene Therapy Market Size and Growth Rate of Lentivirus from 2016 to 2027
-
Figure China Gene Therapy Market Size and Growth Rate of AAV from 2016 to 2027
-
Figure China Gene Therapy Market Size and Growth Rate of Retrovirus & Gammaretrovirus from 2016 to 2027
-
Figure China Gene Therapy Market Size and Growth Rate of Modified Herpes Simplex Virus from 2016 to 2027
-
Figure China Gene Therapy Market Size and Growth Rate of Adenovirus from 2016 to 2027
-
Figure China Gene Therapy Market Size and Growth Rate of Non-viral Plasmid Vector from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Gene Therapy Market Size and Growth Rate of Acute Lymphoblastic Leukemia (ALL) from 2016 to 2027
-
Figure China Gene Therapy Market Size and Growth Rate of Inherited Retinal Disease from 2016 to 2027
-
Figure China Gene Therapy Market Size and Growth Rate of Large B-cell Lymphoma from 2016 to 2027
-
Figure China Gene Therapy Market Size and Growth Rate of ADA-SCID from 2016 to 2027
-
Figure China Gene Therapy Market Size and Growth Rate of Melanoma (Lesions) from 2016 to 2027
-
Figure China Gene Therapy Market Size and Growth Rate of Beta-Thalassemia Major/SCD from 2016 to 2027
-
Figure China Gene Therapy Market Size and Growth Rate of Head & Neck Squamous Cell Carcinoma from 2016 to 2027
-
Figure China Gene Therapy Market Size and Growth Rate of Peripheral Arterial Disease from 2016 to 2027
-
Figure China Gene Therapy Market Size and Growth Rate of Spinal Muscular Atrophy (SMA) from 2016 to 2027
-
Figure China Gene Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Gene Therapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Gene Therapy
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Gene Therapy by Different Types from 2016 to 2027
-
Table Consumption Share of Gene Therapy by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Lentivirus
-
Figure Market Size and Growth Rate of AAV
-
Figure Market Size and Growth Rate of Retrovirus & Gammaretrovirus
-
Figure Market Size and Growth Rate of Modified Herpes Simplex Virus
-
Figure Market Size and Growth Rate of Adenovirus
-
Figure Market Size and Growth Rate of Non-viral Plasmid Vector
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Gene Therapy by Different End-Users from 2016 to 2027
-
Table Consumption Share of Gene Therapy by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Acute Lymphoblastic Leukemia (ALL)
-
Figure Market Size and Growth Rate of Inherited Retinal Disease
-
Figure Market Size and Growth Rate of Large B-cell Lymphoma
-
Figure Market Size and Growth Rate of ADA-SCID
-
Figure Market Size and Growth Rate of Melanoma (Lesions)
-
Figure Market Size and Growth Rate of Beta-Thalassemia Major/SCD
-
Figure Market Size and Growth Rate of Head & Neck Squamous Cell Carcinoma
-
Figure Market Size and Growth Rate of Peripheral Arterial Disease
-
Figure Market Size and Growth Rate of Spinal Muscular Atrophy (SMA)
-
Figure Market Size and Growth Rate of Others
-
Table China Gene Therapy Production by Regions
-
Table China Gene Therapy Production Share by Regions
-
Figure China Gene Therapy Production Share by Regions in 2016
-
Figure China Gene Therapy Production Share by Regions in 2021
-
Figure China Gene Therapy Production Share by Regions in 2027
-
Table China Gene Therapy Consumption by Regions
-
Table China Gene Therapy Consumption Share by Regions
-
Figure China Gene Therapy Consumption Share by Regions in 2016
-
Figure China Gene Therapy Consumption Share by Regions in 2021
-
Figure China Gene Therapy Consumption Share by Regions in 2027
-
Table North China Gene Therapy Consumption by Types from 2016 to 2027
-
Table North China Gene Therapy Consumption Share by Types from 2016 to 2027
-
Figure North China Gene Therapy Consumption Share by Types in 2016
-
Figure North China Gene Therapy Consumption Share by Types in 2021
-
Figure North China Gene Therapy Consumption Share by Types in 2027
-
Table North China Gene Therapy Consumption by End-Users from 2016 to 2027
-
Table North China Gene Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure North China Gene Therapy Consumption Share by End-Users in 2016
-
Figure North China Gene Therapy Consumption Share by End-Users in 2021
-
Figure North China Gene Therapy Consumption Share by End-Users in 2027
-
Table Central China Gene Therapy Consumption by Types from 2016 to 2027
-
Table Central China Gene Therapy Consumption Share by Types from 2016 to 2027
-
Figure Central China Gene Therapy Consumption Share by Types in 2016
-
Figure Central China Gene Therapy Consumption Share by Types in 2021
-
Figure Central China Gene Therapy Consumption Share by Types in 2027
-
Table Central China Gene Therapy Consumption by End-Users from 2016 to 2027
-
Table Central China Gene Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Gene Therapy Consumption Share by End-Users in 2016
-
Figure Central China Gene Therapy Consumption Share by End-Users in 2021
-
Figure Central China Gene Therapy Consumption Share by End-Users in 2027
-
Table South China Gene Therapy Consumption by Types from 2016 to 2027
-
Table South China Gene Therapy Consumption Share by Types from 2016 to 2027
-
Figure South China Gene Therapy Consumption Share by Types in 2016
-
Figure South China Gene Therapy Consumption Share by Types in 2021
-
Figure South China Gene Therapy Consumption Share by Types in 2027
-
Table South China Gene Therapy Consumption by End-Users from 2016 to 2027
-
Table South China Gene Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure South China Gene Therapy Consumption Share by End-Users in 2016
-
Figure South China Gene Therapy Consumption Share by End-Users in 2021
-
Figure South China Gene Therapy Consumption Share by End-Users in 2027
-
Table East China Gene Therapy Consumption by Types from 2016 to 2027
-
Table East China Gene Therapy Consumption Share by Types from 2016 to 2027
-
Figure East China Gene Therapy Consumption Share by Types in 2016
-
Figure East China Gene Therapy Consumption Share by Types in 2021
-
Figure East China Gene Therapy Consumption Share by Types in 2027
-
Table East China Gene Therapy Consumption by End-Users from 2016 to 2027
-
Table East China Gene Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure East China Gene Therapy Consumption Share by End-Users in 2016
-
Figure East China Gene Therapy Consumption Share by End-Users in 2021
-
Figure East China Gene Therapy Consumption Share by End-Users in 2027
-
Table Northeast China Gene Therapy Consumption by Types from 2016 to 2027
-
Table Northeast China Gene Therapy Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Gene Therapy Consumption Share by Types in 2016
-
Figure Northeast China Gene Therapy Consumption Share by Types in 2021
-
Figure Northeast China Gene Therapy Consumption Share by Types in 2027
-
Table Northeast China Gene Therapy Consumption by End-Users from 2016 to 2027
-
Table Northeast China Gene Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Gene Therapy Consumption Share by End-Users in 2016
-
Figure Northeast China Gene Therapy Consumption Share by End-Users in 2021
-
Figure Northeast China Gene Therapy Consumption Share by End-Users in 2027
-
Table Southwest China Gene Therapy Consumption by Types from 2016 to 2027
-
Table Southwest China Gene Therapy Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Gene Therapy Consumption Share by Types in 2016
-
Figure Southwest China Gene Therapy Consumption Share by Types in 2021
-
Figure Southwest China Gene Therapy Consumption Share by Types in 2027
-
Table Southwest China Gene Therapy Consumption by End-Users from 2016 to 2027
-
Table Southwest China Gene Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Gene Therapy Consumption Share by End-Users in 2016
-
Figure Southwest China Gene Therapy Consumption Share by End-Users in 2021
-
Figure Southwest China Gene Therapy Consumption Share by End-Users in 2027
-
Table Northwest China Gene Therapy Consumption by Types from 2016 to 2027
-
Table Northwest China Gene Therapy Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Gene Therapy Consumption Share by Types in 2016
-
Figure Northwest China Gene Therapy Consumption Share by Types in 2021
-
Figure Northwest China Gene Therapy Consumption Share by Types in 2027
-
Table Northwest China Gene Therapy Consumption by End-Users from 2016 to 2027
-
Table Northwest China Gene Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Gene Therapy Consumption Share by End-Users in 2016
-
Figure Northwest China Gene Therapy Consumption Share by End-Users in 2021
-
Figure Northwest China Gene Therapy Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Celladon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celladon
-
Figure Sales and Growth Rate Analysis of Celladon
-
Figure Revenue and Market Share Analysis of Celladon
-
Table Product and Service Introduction of Celladon
-
Table Company Profile and Development Status of Advantagene
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advantagene
-
Figure Sales and Growth Rate Analysis of Advantagene
-
Figure Revenue and Market Share Analysis of Advantagene
-
Table Product and Service Introduction of Advantagene
-
Table Company Profile and Development Status of Sangamo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo
-
Figure Sales and Growth Rate Analysis of Sangamo
-
Figure Revenue and Market Share Analysis of Sangamo
-
Table Product and Service Introduction of Sangamo
-
Table Company Profile and Development Status of Dimension Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dimension Therapeutics
-
Figure Sales and Growth Rate Analysis of Dimension Therapeutics
-
Figure Revenue and Market Share Analysis of Dimension Therapeutics
-
Table Product and Service Introduction of Dimension Therapeutics
-
Table Company Profile and Development Status of Vical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vical
-
Figure Sales and Growth Rate Analysis of Vical
-
Figure Revenue and Market Share Analysis of Vical
-
Table Product and Service Introduction of Vical
-
Table Company Profile and Development Status of Avalanche Bio
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Avalanche Bio
-
Figure Sales and Growth Rate Analysis of Avalanche Bio
-
Figure Revenue and Market Share Analysis of Avalanche Bio
-
Table Product and Service Introduction of Avalanche Bio
-
Table Company Profile and Development Status of Spark Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spark Therapeutics
-
Figure Sales and Growth Rate Analysis of Spark Therapeutics
-
Figure Revenue and Market Share Analysis of Spark Therapeutics
-
Table Product and Service Introduction of Spark Therapeutics
-
